Summary by Futu AI
Virpax Pharmaceuticals, Inc. (Virpax) has announced the offering of 937,034 shares of common stock, along with 1,666,667 Series A-1 and Series A-2 Common Warrants to purchase up to an equal number of shares of common stock. Additionally, 729,633 Pre-Funded Warrants to purchase up to 729,633 shares of common stock are being offered. The public offering price is set at $1.35 per share of common stock and accompanying warrants. The Series A-1 Common Warrants are exercisable immediately upon issuance at $1.35 per share and will expire five years from the date of issuance, while the Series A-2 Common Warrants have the same exercise price but will expire 18 months from the date of issuance. The Pre-Funded Warrants, exercisable for one share of common stock at $0.00001 per...Show More